Mostrar el registro sencillo del ítem

Artículo

dc.creatorEspinal, P.es
dc.creatorMacià, M. D.es
dc.creatorRoca, I.es
dc.creatorFernández-Cuenca, Felipees
dc.creatorOliver, A.es
dc.creatorRodríguez-Baño, Jesúses
dc.creatorBou, Germánes
dc.creatorTomás, M.es
dc.creatorVilla, J.es
dc.date.accessioned2016-04-28T17:59:17Z
dc.date.available2016-04-28T17:59:17Z
dc.date.issued2013-01
dc.identifier.issn0066-4804es
dc.identifier.urihttp://hdl.handle.net/11441/40594
dc.description.abstractA carbapenem-resistant Acinetobacter baumannii clinical isolate belonging to European clone II and sequence type 2 was recov-ered from a patient in the Son Espases hospital in Mallorca, Spain. Genetic analysis showed the presence of the bla OXA-23 gene in association with the widely disseminated transposon Tn2006. This is the first reported identification of A. baumannii carrying bla OXA-23 in Spain.es
dc.formatapplication/pdfes
dc.language.isoenges
dc.publisherAmerican Society for Microbiologyes
dc.relation.ispartofAntimicrobial Agents and Chemotherapy 57(1), 589–591es
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleFirst Report of an OXA-23 Carbapenemase-Producing Acinetobacter baumannii Clinical Isolate Related to Tn2006 in Spaines
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.relation.publisherversionhttp://aac.asm.org/content/57/1/589.fulles
dc.identifier.doihttp://dx.doi.org/10.1128/AAC.01157-12es
idus.format.extent3es
dc.identifier.idushttps://idus.us.es/xmlui/handle/11441/40594

FicherosTamañoFormatoVerDescripción
20440823.pdf154.7KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional